Skip to main content Accessibility help
  • Print publication year: 2007
  • Online publication date: September 2010

11 - Imaging of metastatic disease

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Colorectal Cancer
  • Online ISBN: 9780511902468
  • Book DOI:
Please enter your name
Please enter a valid email address
Who would you like to send this to *
Petrowsky, H., Gonen, M., Jarnagin, W., et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg, 235:6 (2002), 863–71.
Shaw, I. M., Rees, M., Welsh, F. K., Bygrave, S., and John, T. G.Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg, 93:4 (2006), 457–64.
Ogata, Y., Matono, K., Hayashi, A., et al. Repeat pulmonary resection for isolated recurrent lung metastases yields results comparable to those after first pulmonary resection in colorectal cancer. World J Surg, 29:3 (2005), 363–8.
Cummins, E. R., Vick, K. D., and Poole, G. V.Incurable colorectal carcinoma: the role of surgical palliation. Am Surg, 70:5 (2004), 433–7.
Choti, M. A., Sitzmann, J. V., Tiburi, M. F., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg, 235:6 (2002), 759–66.
Wei, A. C., Greig, P. D., Grant, D., et al. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol, 13:5 (2006), 668–76.
Elias, D., Blot, F., Otmany, El A., et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intra-peritoneal chemotherapy. Cancer, 92:1 (2001), 71–6.
Renehan, A. G., Egger, M., Saunders, M. P., and O'Dwyer, S. T.Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ, 324:7341 (2002), 813.
Chau, I., Allen, M. J., Cunningham, D., et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol, 22:8 (2004), 1420–9.
Dukes, C. and Bussey, H. J.Venous spread in rectal cancer. Proc R Soc Med, 34 (1941), 571–3.
Sunderland, D.The significance of vein invasion by cancer of the rectum and sigmoid: a microscopic study of 210 cases. Cancer, 2 (1949), 429–37.
Lui, K. K., Enjoji, M., and Inokuchi, K.Venous permeation of colorectal carcinoma. Jpn J Surg, 10:4 (1980), 284–9.
Talbot, I. C., Ritchie, S., Leighton, M. H., et al. The clinical significance of invasion of veins in cancer of the rectum. Br J Surg, 67:6 (1980), 439–42.
Horn, A., Dahl, O., and Morild, I.Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum, 34:9 (1991), 798–804.
Talbot, I. C., Ritchie, S., Leighton, M. H., et al. Spread of rectal cancer within veins. Histologic features and clinical significance. Am J Surg, 141:1 (1981), 15–17.
Birnkrant, A., Sampson, J., and Sugarbaker, P. H.Ovarian metastasis from colorectal cancer. Dis Colon Rectum, 29:11 (1986), 767–71.
Sundermeyer, M. L., Meropol, N. J., Rogatko, A., Wang, H., and Cohen, S. J.Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer, 5:2 (2005), 108–13.
Reinhardt, M. J., Wiethoelter, N., Matthies, A., et al. PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. Eur J Nucl Med Mol Imaging, 33:2 (2006), 134–9.
Imdahl, A., Fischer, E., Tenckhof, C., et al. [Resection of combined or sequential lung and liver metastases of colorectal cancer: indication for everyone?]. Zentralbl Chir, 130:6 (2005), 539–43.
McCormack, P. M., Burt, M. E., Bains, M. S., et al. Lung resection for colorectal metastases. 10-year results. Arch Surg, 127:12 (1992), 1403–6.
Ike, H., Shimada, H., Ohki, S., et al. Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up. Dis Colon Rectum, 45:4 (2002), 468–73, discussion 473–5.
Cho, K. C. and Gold, B. M.Computed tomography of Krukenberg tumors. AJR Am J Roentgenol, 145:2 (1985), 285–8.
Kuhlman, J. E., Hruban, R. H., and Fishman, E. K.Krukenberg tumors: CT features and growth characteristics. South Med J, 82:10 (1989), 1215–19.
Kim, S. H., Kim, W. H., Park, K. J., Lee, J. K., and Kim, J. S.CT and MR findings of Krukenberg tumors: comparison with primary ovarian tumors. J Comput Assist Tomogr, 20:3 (1996), 393–8.
Perdomo, J. A., Hizuta, A., Iwagaki, H., et al. Ovarian metastasis in patients with colorectal carcinoma. Acta Med Okayama, 48:1 (1994), 43–6.
Sielezneff, I., Salle, E., Antoine, K., et al. Simultaneous bilateral oophorectomy does not improve prognosis of post-menopausal women undergoing colorectal resection for cancer. Dis Colon Rectum, 40:11 (1997), 1299–302.
Sakakura, C., Hagiwara, A., Yamazaki, J., et al. Management of post-operative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers. Hepatogastroenterology, 51:59 (2004), 1350–3.
Banerjee, S., Kapur, S., and Moran, B. J.The role of prophylactic oophorectomy in women undergoing surgery for colorectal cancer. Colorectal Dis, 7:3 (2005), 214–17.
DeMeo, J. H., Fulcher, A. S., and Austin, R. F. Jr.Anatomic CT demonstration of the peritoneal spaces, ligaments, and mesenteries: normal and pathologic processes. Radiographics, 15:4 (1995), 755–70.
Coakley, F. V. and Hricak, H.Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. Clin Radiol, 54:9 (1999), 563–74.
Meyers, M. A., Oliphant, M., Berne, A. S., and Feldberg, M. A.The peritoneal ligaments and mesenteries: pathways of intra-abdominal spread of disease. Radiology, 163:3 (1987), 593–604.
Glehen, O., Kwiatkowski, F., Sugarbaker, P. H., et al. Cytoreductive surgery combined with peri-operative intra-peritoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol, 22:16 (2004), 3284–92.
Sugarbaker, P. H., Schellinx, M. E., Chang, D., Koslowe, P., and Meyerfeldt, M.Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg, 20:5 (1996), 585–91, discussion 592.
Geoghegan, J. G. and Scheele, J.Treatment of colorectal liver metastases. Br J Surg, 86:2 (1999), 158–69.
Jaeck, D., Bachellier, P., Guiguet, M., et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg, 84:7 (1997), 977–80.
Fong, Y., Cohen, A. M., Fortner, J. G., et al. Liver resection for colorectal metastases. J Clin Oncol, 15:3 (1997), 938–46.
Foroutani, A., Garland, A. M., Berber, E., et al. Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors. Arch Surg, 135:8 (2000), 933–8.
Cervone, A., Sardi, A., and Conaway, G. L.Intra-operative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg, 66:7 (2000), 611–15.
Nordlinger, B. and Wind, P.Repeat resections of primary hepatic malignancies. Cancer Treat Res, 69 (1994), 53–6.
Clavien, P. A., Selzner, N., Morse, M., Selzner, M., and Paulson, E.Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery, 131:4 (2002), 433–42.
Shankar, A., Leonard, P., Renaut, A. J., et al. Neo-adjuvant therapy improves resectability rates for colorectal liver metastases. Ann R Coll Surg Engl, 83:2 (2001), 85–8.
Adam, R., Avisar, E., Ariche, A., et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol, 8:4 (2001), 347–53.
Giacchetti, S., Itzhaki, M., Gruia, G., et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol, 10:6 (1999), 663–9.
Fong, Y., Fortner, J., Sun, R. L., Brennan, M. F., and Blumgart, L. H.Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg, 230:3 (1999), 309–18, discussion 318–21.
Jarnagin, W. R., Fong, Y., Ky, A., et al. Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg, 188:1 (1999), 33–42.
Strasberg, S. M., Dehdashti, F., Siegel, B. A., Drebin, J. A., and Linehan, D.Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg, 233:3 (2001), 293–9.
Schussler-Fiorenza, C. M., Mahvi, D. M., Niederhuber, J., Rikkers, L. F., and Weber, S. M.Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases. J Gastrointest Surg, 8:2 (2004), 150–7, discussion 157–8.
Glover, C., Douse, P., Kane, P., et al. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum, 45:4 (2002), 476–84.
Siosteen, A. K. and Elvin, A.Intra-operative uses of contrast-enhanced ultrasound. Eur Radiol, 14:suppl. 8 (2004), P87–95.
Ridge, J. A., Bading, J. R., Gelbard, A. S., Benua, R. S., and Daly, J. M.Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer, 59:9 (1987), 1547–53.
Valls, C., Andia, E., Sanchez, A., et al. Hepatic metastases from colorectal cancer: pre-operative detection and assessment of resectability with helical CT. Radiology, 218:1 (2001), 55–60.
Wong, K., Paulson, E. K., and Nelson, R. C.Breath-hold three-dimensional CT of the liver with multi-detector row helical CT. Radiology, 219:1 (2001), 75–9.
Scott, D. J., Guthrie, J. A., Arnold, P., et al. Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings. Clin Radiol, 56:3 (2001), 235–42.
Ch'en, I. Y., Katz, D. S., Jeffrey, R. B. Jr., et al. Do arterial phase helical CT images improve detection or characterization of colorectal liver metastases?J Comput Assist Tomogr, 21:3 (1997), 391–7.
Jang, H. J., Lim, H. K., Lee, W. J., et al. Small hypoattenuating lesions in the liver on single-phase helical CT in pre-operative patients with gastric and colorectal cancer: prevalence, significance, and differentiating features. J Comput Assist Tomogr, 26:5 (2002), 718–24.
Semelka, R. C., Martin, D. R., Balci, C., and Lance, T.Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging, 13:3 (2001), 397–401.
Reimer, P., Jahnke, N., Fiebich, M., et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology, 217:1 (2000), 152–8.
Koh, D. M., Brown, G., Meer, Z., Norman, A. R., and Husband, J. E.Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium. AJR Am J Roentgenol, 188:2 (2007), W154–61.
Young, S. W., Bradley, B., Muller, H. H., and Rubin, D. L.Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent. Magn Reson Imaging, 8:3 (1990), 267–76.
Mann, G. N., Marx, H. F., Lai, L. L., and Wagman, L. D.Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the pre-operative assessment of liver resectability. Ann Surg Oncol, 8:7 (2001), 573–9.
Kinkel, K., Lu, Y., Both, M., Warren, R. S., and Thoeni, R. F.Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology, 224:3 (2002), 748–56.
Park, K. C., Schwimmer, J., Shepherd, J. E., et al. Decision analysis for the cost-effective management of recurrent colorectal cancer. Ann Surg, 233:3 (2001), 310–19.